Logo image of BSK.CA

BLUE SKY URANIUM CORP (BSK.CA) Stock Fundamental Analysis

Canada - TSX-V:BSK - CA0960495079 - Common Stock

0.065 CAD
+0.01 (+8.33%)
Last: 10/30/2025, 7:00:00 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to BSK. BSK was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. BSK has a bad profitability rating. Also its financial health evaluation is rather negative. BSK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BSK had negative earnings in the past year.
In the past year BSK has reported a negative cash flow from operations.
BSK had negative earnings in each of the past 5 years.
BSK had a negative operating cash flow in each of the past 5 years.
BSK.CA Yearly Net Income VS EBIT VS OCF VS FCFBSK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

The Return On Assets of BSK (-331.82%) is worse than 90.95% of its industry peers.
Industry RankSector Rank
ROA -331.82%
ROE N/A
ROIC N/A
ROA(3y)-373.44%
ROA(5y)-290.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BSK.CA Yearly ROA, ROE, ROICBSK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

BSK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BSK.CA Yearly Profit, Operating, Gross MarginsBSK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

BSK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BSK has been increased compared to 5 years ago.
Compared to 1 year ago, BSK has a worse debt to assets ratio.
BSK.CA Yearly Shares OutstandingBSK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
BSK.CA Yearly Total Debt VS Total AssetsBSK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

BSK has an Altman-Z score of -52.80. This is a bad value and indicates that BSK is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BSK (-52.80) is worse than 89.52% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -52.8
ROIC/WACCN/A
WACCN/A
BSK.CA Yearly LT Debt VS Equity VS FCFBSK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

A Current Ratio of 0.64 indicates that BSK may have some problems paying its short term obligations.
BSK has a Current ratio of 0.64. This is in the lower half of the industry: BSK underperforms 67.62% of its industry peers.
BSK has a Quick Ratio of 0.64. This is a bad value and indicates that BSK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.64, BSK is not doing good in the industry: 60.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.64
BSK.CA Yearly Current Assets VS Current LiabilitesBSK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BSK have decreased strongly by -34.38% in the last year.
EPS 1Y (TTM)-34.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BSK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BSK.CA Price Earnings VS Forward Price EarningsBSK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSK.CA Per share dataBSK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BSK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE SKY URANIUM CORP

TSX-V:BSK (10/30/2025, 7:00:00 PM)

0.065

+0.01 (+8.33%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-20 2023-11-20
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.71%
Ins Owner ChangeN/A
Market Cap23.67M
Revenue(TTM)N/A
Net Income(TTM)-5318700
Analysts84.44
Price Target0.15 (130.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -331.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-373.44%
ROA(5y)-290.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z -52.8
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-72.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.8%
OCF growth 3YN/A
OCF growth 5YN/A

BLUE SKY URANIUM CORP / BSK.CA FAQ

What is the ChartMill fundamental rating of BLUE SKY URANIUM CORP (BSK.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to BSK.CA.


What is the valuation status of BLUE SKY URANIUM CORP (BSK.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to BLUE SKY URANIUM CORP (BSK.CA). This can be considered as Overvalued.


How profitable is BLUE SKY URANIUM CORP (BSK.CA) stock?

BLUE SKY URANIUM CORP (BSK.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for BSK stock?

The financial health rating of BLUE SKY URANIUM CORP (BSK.CA) is 0 / 10.